Post Doctoral Training Fellow - Target Biology and Genomic Instability

23/02/2020, 23:55

Sutton
Cancer Therapeutics
Target Biology and Genomic Instability
Full time
Fixed Term
2 years
35
£32,200 - £40,100
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top five cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The team led by Dr Anderson Wang is looking for two experienced Post Doctoral Training Fellows in DNA damage response and cancer therapeutics. This position is critical for strengthening our drug discovery portfolio and supporting biology teams within the CRUK Cancer Therapeutics Unit in Sutton. 

The post holder is required to have a PhD in a biological science or equivalent experience, and to have extensive experience in tissue culture, cell biology, biochemistry and in particular DNA damage response field. Please refer to the attached job description and person-specification for full details. Please note there are 2 positions available in the team.

This appointment is for two years in the first instance. Salary is based on Post Doctoral Training Fellow Pay Grade. Progression is determined by annual performance review. Starting salary will be based on previous experience.

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.

In partnership with

Cancer Research UK
Additional Documentation for Candidates

This Program is closed to applications.